Alcon AG | ALC - Ordinary Share Capital



Alcon AG reported $20M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 1.16B Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Essilor EUR 456.71M 374.71M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Philips EUR 950.57M 762.57M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
Smith & Nephew USD 875.96M 700.96M Jun/2025
Sonova Holding CHF 3M 0 Sep/2024
UCB EUR 584M 0 Dec/2024